An interventional study of Single-stage laparoscopic stapled conversion of gastric bypass to sleeve gastrectomy in Gastric Bypass Complication, Obesity and Bariatric Surgery Candidate, sponsored by Kasr El Aini Hospital. Completed at 1 site in Egypt. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-11-03.
Sponsored by Kasr El Aini Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 138 studies in Obesity with a site in Egypt — 32 open to participants now, 39 under way, none of them phase 3. Obesity · Egypt.
Among the 138 studies in Obesity with a site in Egypt, this one is the 98th largest by enrollment of the 102 interventional ones that give a count, is one of 23 that started in 2025, is one of 90 with no phase, and was the 94th registered.
11,560 studies on the registry are indexed under Obesity; 2,063 are open to participants now.
Browse Obesity studies →32 of the 138 studies in Obesity with a site in Egypt are open now. Recruiting first, the newest first:
Cairo University · Sites in Egypt
Ages 18+
Cairo University · Sites in Egypt
Ages 60–70 · Women only
Badr University · Sites in Egypt
Ages 36–58
Cairo University · Sites in Egypt
Ages 40–55
Cairo University · Sites in Egypt
Ages 18–60
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.
This study: 18 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
138 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 6 · Phase 3 2 · Phase 4 3
First in 2006; this study’s year is marked. 23 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 11 is below the median of 67 across 9,043 interventional studies indexed under Obesity.
Median enrollment 60 across the 102 interventional studies, 100 across the 36 observational. Of the 87 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 138 have an industry lead sponsor. The 10 most frequent:
Kasr El Aini Hospital is the lead sponsor of 288 studies on the registry; 35 are open to participants now.
Kasr El Aini Hospital has 6 studies filed under Obesity — fewer than ten, so there is no comparison to draw.
7 of the studies in Obesity with a site in Egypt that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07397572Cairo UniversityIron Supplementation and Anemia After Sleeve Gastrectomy | 2026-11 |
| NCT06901440Assiut UniversityBariatric Surgery for Obesity | 2026-12 |
| NCT07336797Abdelrahman MahmoudEffect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy | 2026-12-30 |
| NCT07683286Cairo UniversityPilates Exercises Versus Intermittent Fasting Diet on Physical and Metabolic Aging Process in Obese Perimenopausal Women | 2027-01-01 |
| NCT07857395Zagazig UniversityModified El-Ganzouri Risk Index for Predicting Difficult Intubation in Obese Patients | 2027-03-31 |
Add all 7 to your calendar (.ics) → With an account.
Among the 138 studies in Obesity with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Some patients who have had a gastric bypass (Roux-en-Y gastric bypass or one anastomosis gastric bypass) develop long-term problems such as nutritional deficiencies, intractable dumping syndrome, retrograde intussusception or weight regain, and some cannot afford the lifelong vitamin supplements the bypass requires. When these problems do not respond to non-surgical treatment, the bypass can be reversed to normal anatomy, but many patients refuse reversal because they fear regaining weight. Converting the bypass to a sleeve gastrectomy is an alternative that restores food passage through the duodenum while keeping a restrictive operation.
This single-arm study evaluates the efficacy, safety and patient outcomes of single-stage laparoscopic stapled conversion of gastric bypass to sleeve gastrectomy in adults at Kasr Al-Ainy hospitals, Cairo University. Patients are followed for 6 months after surgery for nutritional status, weight regain, quality of life, reflux (GERD) symptoms and postoperative complications, including leak.
Background: Laparoscopic gastric bypass, including Roux-en-Y gastric bypass (RYGB) and one anastomosis gastric bypass (OAGB), is one of the most frequently performed metabolic bariatric procedures. As the number of bypass operations increases, complications are reported more often. Most can be managed non-surgically, but a small number of persistent cases require reversal to normal anatomy or conversion to another procedure. Complications that may require conversion include retrograde intussusception, weight regain, intractable dumping syndrome and nutritional deficiencies; the high cost of obligatory postoperative vitamins is a further reason for conversion in low-income countries. Conversion is technically demanding, carries a relatively higher rate of postoperative complications, and data on its outcomes are limited.
Design: Prospective, single-arm interventional study.
Preoperative assessment: Patients attending the bariatric outpatient clinic who meet the eligibility criteria are enrolled after patient education. History, anthropometric measures, chronic diseases and previous surgeries are recorded. Routine preoperative laboratory tests and imaging are performed, together with a preoperative 3D CT gastric volumetry.
Surgical technique: After pneumoperitoneum and laparoscopic port placement, the previous gastrojejunostomy is closed with an endostapler applied across the anastomosis and fired on the jejunal side. The end of the gastric pouch is then anastomosed to the remnant stomach with an endostapler. A 36 Fr orogastric tube is passed through the anastomosis as a guide, and a sleeve gastrectomy is performed by resecting the stomach along the greater curvature with endostaplers. An intraoperative methylene blue leak test is performed, hemostasis along the staple line is confirmed, and all ports are closed.
Postoperative care and follow-up: Patients stay in hospital for about 24 hours for monitoring of vital signs and the feeding regimen. Nutritional laboratory parameters (hemoglobin, ferritin, vitamin D, zinc, magnesium, serum albumin and calcium), quality of life (Bariatric Quality of Life Index) and GERD symptoms (GERD-HRQL questionnaire) are assessed at 3 and 6 months after surgery. Body weight is recorded monthly to assess weight regain.
Sample size: Calculated with the ClinCalc sample size calculator (alpha 0.05, power 0.80) as 11 patients, including 10% to cover loss to follow-up. A convenience sample of eligible patients is enrolled until this number is reached.
Statistical analysis: SPSS version 21. Categorical data as number and percentage; quantitative data as mean and standard deviation or median and interquartile range. Chi-square, Student t and Mann-Whitney tests, with correlation and regression analysis. Significance at p of 0.05 or less.
The criteria were revised on the registry on Nov 3, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Adults with a previous gastric bypass (RYGB or OAGB) undergoing single-stage laparoscopic stapled conversion to sleeve gastrectomy.
Procedure: Single-stage laparoscopic stapled conversion of gastric bypass to sleeve gastrectomy
Stapled closure of the previous gastrojejunostomy on the jejunal side, stapled anastomosis of the gastric pouch to the remnant stomach, then sleeve gastrectomy along the greater curvature over a 36 Fr orogastric tube, with an intraoperative methylene blue leak test.
Postoperative leak
Number of participants with a staple-line or anastomotic leak after single-stage stapled conversion of gastric bypass to sleeve gastrectomy.
Time frame: From surgery up to 6 months after surgery
Change in nutritional status
Nutritional status assessed with laboratory parameters: hemoglobin, serum ferritin, vitamin D, zinc, magnesium, serum albumin and calcium.
Time frame: Preoperatively, and at 3 and 6 months after surgery
Weight regain
Body weight (kg) recorded monthly after conversion to assess weight regain.
Time frame: Monthly from surgery up to 6 months after surgery
Quality of life (Bariatric Quality of Life Index)
Quality of life assessed with the Bariatric Quality of Life (BQL) Index.
Time frame: 3 and 6 months after surgery
GERD symptoms (GERD-Health Related Quality of Life questionnaire)
Gastroesophageal reflux symptoms assessed with the GERD-Health Related Quality of Life (GERD-HRQL) questionnaire.
Time frame: 3 and 6 months after surgery
Other postoperative complications
Number of participants with postoperative complications other than leak, including bleeding and stricture.
Time frame: From surgery up to 6 months after surgery
Plan to share: No
No publications or documents are linked to this record.
Ran from Feb 2025 to primary completion in Oct 2026, 19 months.
Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's 19 months is below that.
Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.
Start moved once since we started tracking on Sep 25, 2026: Jan 2025 → Feb 2025, on Nov 3, 2026.
Primary completion moved twice since we started tracking on Sep 25, 2026: Jan 2026 → Oct 2026, last on Nov 3, 2026.
Completion moved twice since we started tracking on Sep 25, 2026: Jan 2026 → Oct 2026, last on Nov 3, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.